These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9934543)

  • 21. Cefotaxime twice daily versus ceftriaxone once daily. A randomized controlled study in patients with serious infections.
    Simmons BP; Gelfand MS; Grogan J; Craft B
    Diagn Microbiol Infect Dis; 1995; 22(1-2):155-7. PubMed ID: 7587031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefotaxime dosage in infants and children. Pharmacokinetic and clinical rationale for an extended dosage interval.
    Kearns GL; Young RA; Jacobs RF
    Clin Pharmacokinet; 1992 Apr; 22(4):284-97. PubMed ID: 1606788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cefodizime given in single or divided doses for the treatment of lower respiratory tract infection.
    Palombini BC; André-Alves MR; Dagrosa EE
    Arzneimittelforschung; 1997 Mar; 47(3):299-302. PubMed ID: 9105549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefodizime once daily in the treatment of lower respiratory tract infections.
    Piovano CF; Palombini BC; Dagrosa EE; Mendoza F; Facco EB
    Arzneimittelforschung; 1997 May; 47(5):674-7. PubMed ID: 9205786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A comparative study between cefodizime (CDZM) and cefotaxime (CTX) in respiratory tract infections].
    Takebe K; Imamura K; Masuda M; Murakami S; Tomiyama M; Tamura T; Endou K; Ishimaru K; Okushima T; Nakazono M
    Kansenshogaku Zasshi; 1989 Apr; 63(4):318-51. PubMed ID: 2506292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of ceftriaxone in pediatric infections].
    Ohnuma M; Watanabe A
    Jpn J Antibiot; 1984 Nov; 37(11):2015-20. PubMed ID: 6098697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NONMEM analysis in determining the tri-exponential disposition of cefotaxime: a method of evaluating serum and urinary phase I data.
    Weber W; Harnisch L; Zimmer M; Rokitta C; Mendes P
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):560-4. PubMed ID: 8574507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical studies on ceftriaxone in the pediatric field].
    Aoyama R; Ito E; Ohnishi A; Izumi Y; Nagata K; Yokoyama M; Kuronuma T; Fujita M
    Jpn J Antibiot; 1984 Nov; 37(11):2012-4. PubMed ID: 6098696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A retrospective analysis of twice-daily cefotaxime compared to conventional therapy for the treatment of infections in a USA hospital.
    Burke JP; Pestotnik SL; Classen DC; Lloyd JF
    Diagn Microbiol Infect Dis; 1995; 22(1-2):167-9. PubMed ID: 7587034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical studies on cefmenoxime in the pediatric field].
    Okamoto K; Shino K; Fuke H; Watanabe K; Ozaki H
    Jpn J Antibiot; 1982 Nov; 35(11):2545-54. PubMed ID: 6302336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective analysis of the clinical and economic outcomes of twice-daily dosing of cefotaxime in a Canadian tertiary care institution.
    Tin LY; Pitre M; Conly JM
    Diagn Microbiol Infect Dis; 1995; 22(1-2):135-40. PubMed ID: 7587028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefuroxime axetil: an updated review of its use in the management of bacterial infections.
    Scott LJ; Ormrod D; Goa KL
    Drugs; 2001; 61(10):1455-500. PubMed ID: 11558834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical studies of cefixime granules in pediatrics].
    Nakazawa S; Sato H; Narita A; Nakazawa S; Suzuki H; Matsumoto K; Chikaoka H; Kamigaki M; Koido R; Niino K
    Jpn J Antibiot; 1986 Apr; 39(4):1020-34. PubMed ID: 3761535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefixime in the treatment of respiratory and urinary tract infections.
    Ludwig E
    Chemotherapy; 1998 Sep; 44 Suppl 1():31-4. PubMed ID: 9797422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of cefixime in pediatric respiratory tract infections].
    Iwai N; Nakamura H; Kasai K; Ozaki T; Matsui Y; Tauchi N; Yamaguchi H; Taneda Y; Maki T
    Jpn J Antibiot; 1991 Jan; 44(1):35-47. PubMed ID: 2041146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Empiric use of cefepime in the treatment of lower respiratory tract infections in children.
    Bradley JS; Arrieta A
    Pediatr Infect Dis J; 2001 Mar; 20(3):343-9. PubMed ID: 11303848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous vs. intermittent cefotaxime administration in patients with chronic obstructive pulmonary disease and respiratory tract infections: pharmacokinetics/pharmacodynamics, bacterial susceptibility and clinical efficacy.
    van Zanten AR; Oudijk M; Nohlmans-Paulssen MK; van der Meer YG; Girbes AR; Polderman KH
    Br J Clin Pharmacol; 2007 Jan; 63(1):100-9. PubMed ID: 16869814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of cefotaxime in dialysis patients.
    Andrassy K
    Diagn Microbiol Infect Dis; 1995; 22(1-2):85-7. PubMed ID: 7587055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fundamental and clinical evaluation of ceftriaxone in the pediatric field].
    Sunakawa K; Saitoh N; Adachibara A; Ishizuka Y; Iwata S; Satoh Y; Akita H
    Jpn J Antibiot; 1984 Nov; 37(11):2102-10. PubMed ID: 6098704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and bacteriological studies of ceftriaxone (CTRX) once daily administration in pediatric patients with respiratory tract infections].
    Hasui M; Kobayashi Y; Harada Y; Ono A; Okazaki H; Kino M; Hara T
    Jpn J Antibiot; 2001 Oct; 54(10):532-40. PubMed ID: 11771335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.